Back to search
FDAFDA · Food and drugs·Recall number Z-0019-2018

Philips Healthcare Brilliance iCT X-Ray, Tomography, Computed These computed tomography x-ray systems are intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes.

Published October 25, 2017 · Recall initiated: January 18, 2017

Summary

FDA records medical device Class II recall Z-0019-2018, published October 25, 2017 and initiated January 18, 2017. Recalling firm: Philips Electronics North America Corporation; Status: Terminated; Reported quantity: US- 606; Lot: Software version 4.16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

During a bolus tracking procedure, no images were generated when the scan was completed, and the raw data file was not available for offline reconstruction. There is a discrepancy between the calculated reconstruction length and the actual scan length that results in the inability to reconstruct raw data. The operator may choose to rescan the patient.

What to do

FDA Mandated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Philips Electronics North America Corporation
Distributor
USA (nationwide) Distribution
Lot
Software version 4.16
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Philips Healthcare Brilliance iCT X-Ray, Tomography, Computed These computed tomography x-ray systems are intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data taken at different angles and planes. recalled?

Yes. FDA published recall Z-0019-2018 on October 25, 2017. Reported hazard: During a bolus tracking procedure, no images were generated when the scan was completed, and the raw data file was not available for offline reconstruction. There is a discrepancy between the calculated reconstruction length and the actual scan length that results in the inability to reconstruct raw data. The operator may choose to rescan the patient.

What should I do if I have this product?

FDA Mandated · Letter